Why the study?
Recent evidence points to the involvement of ANGPTL3-4-8 in regulating adipose tissue function, alteration of which is considered the main inducer of metabolic syndrome and its related complications.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
ANGPTL3-4-8 may link lipid metabolism to adiposopathy in metabolic syndrome; leaves open targeted interventions pending prospective trials.
Angiopoietin-like proteins, namely ANGPTL3-4-8, are known as regulators of lipid metabolism. However, recent evidence points towards their involvement in the regulation of adipose tissue function. Alteration of adipose tissue functions (also called adiposopathy) is considered the main inducer of metabolic syndrome (MS) and its related complications. In this review, we intended to analyze available evidence derived from experimental and human investigations highlighting the contribution of ANGPTLs in the regulation of adipocyte metabolism, as well as their potential role in common cardiometabolic alterations associated with adiposopathy. We finally propose a model of ANGPTLs-based adipose tissue dysfunction, possibly linking abnormalities in the angiopoietins to the induction of adiposopathy and its related disorders.
No takes yet. Share an insight, caveat, or question.
Bini et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: